Target intelligence / Profile preview

Pyrin domain-containing protein 5 (PYDC5)

Target
PYDC5
Molecular classification
Other (Pyrin domain-only protein, member of the death domain superfamily)
01

Overview

Pyrin domain-containing protein 5 (PYDC5), also known as pyrin domain-only protein 3 (POP3), is a small regulatory protein expressed in humans and encoded by the PYDC5 gene. It consists of a PYRIN domain and functions as a negative regulator of the AIM2 inflammasome, a multiprotein complex involved in the innate immune response to cytosolic double-stranded DNA, including DNA viruses. PYDC5 inhibits the assembly and activation of the AIM2 inflammasome by binding to AIM2, thus modulating downstream inflammatory responses such as interferon-beta signaling and innate immunity to infections[2][3][7]. PYDC5 belongs to the death domain superfamily (specifically the PYRIN domain subfamily), which includes other regulators of cell death and inflammation, but unlike most members, PYDC5 contains only the PYRIN domain and lacks other effector domains. Currently, PYDC5 is not considered a direct therapeutic target, and no drugs have been identified as acting on this protein.

Other names
Pyrin domain-only protein 3POP3POP 3pyrin domain-containing protein 5pyrin domain only protein 3
02

Mechanism of action

Negative regulation of AIM2 inflammasome activation via direct interaction with AIM2 and interference with DNA virus-induced immune response

03

Biological functions

Negative regulation of AIM2 inflammasome complex assemblyInhibitor of DNA virus-induced activation of AIM2-like receptor inflammasomesCellular response to interferon-betaCellular response to virus
04

Disease associations

Inflammation (potential role, given connection with the inflammasome pathway)

Beyond the preview

Go deeper on Pyrin domain-containing protein 5 (PYDC5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyrin domain-containing protein 5 (PYDC5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call